EU Medicines Agency

Latest news from the European Medicines Agency, the European Union agency responsible for the evaluation and supervision of medicines. RTs ≠ endorsement.

[EU Medicines Agency @EMA_News]

We have moved...

We have decided to take a break from X, but we want to keep talking about medicines and public & animal health with all of our followers.

Find us on Bluesky ➡️ https://t.co/Vec4pn4TdE

[ECDC @ECDC_EU]

#JustPublished:
The Chinese CDC has reported a sharp increase in respiratory viral infections, including #hMPV infections.

Based on the current information, ECDC considers that the current situation does not pose any specific concern for the EU/EEA.

https://t.co/7fac1gz0Cx

[EU Medicines Agency @EMA_News]

Join us for another “Conversations on Cancer” session, as we mark #CervicalCancerAwarenessMonth.

📅January 14, 16:00-17:00 CET | 10:00-11:00 AM ET
🔗Registration: https://t.co/W9XBc54HIL

[EU One Health @EU_Health]

🎗️January is #CervicalCancerAwarenessMonth.
Vaccination is a safe & an effective way to prevent cervical cancer. As part of the #EUCancerPlan, we aim to boost the HPV vaccines uptake across the EU.
Find out more:
🔗https://t.co/dJbdMC9OeY
#UnitedInProtection #HealthUnion

[EU Medicines Agency @EMA_News]

GLP-1s like #Ozempic, #Saxenda, #Wegovy, or #Mounjaro are not an easy #weightloss hack.

Find out more about:
🔵what they are ❓
🔵how they're used 💊
🔵who they help 💪

🔗Learn more: https://t.co/GY4a7VRAgF

[EU Medicines Agency @EMA_News]

Do you know how medicines get their name? 🤔Find out more in this video.

[EU Medicines Agency @EMA_News]

Every year, 300,000 children face cancer. While survival rates are up to 85%, disparities remain. EMA is committed to advancing treatments with targeted therapies, better clinical trials, and global partnershipsEvery year, 300,000 children face cancer. While survival rates are up to 85%, disparities remain. EMA is committed to advancing treatments with targeted therapies, better clinical trials, and global partnershipsEvery year, 300,000 children face cancer. While survival rates are up to 85%, disparities remain. EMA is committed to advancing treatments with targeted therapies, better clinical trials, and global partnershipsEvery year, 300,000 children face cancer. While survival rates are up to 85%, disparities remain. EMA is committed to advancing treatments with targeted therapies, better clinical trials, and global partnershipsEvery year, 300,000 children face cancer. While survival rates are up to 85%, disparities remain. EMA is committed to advancing treatments with targeted therapies, better clinical trials, and global partnerships.

[EU Medicines Agency @EMA_News]

How can you help prevent shortages of antibiotics this seasonHow can you help prevent shortages of antibiotics this seasonHow can you help prevent shortages of antibiotics this seasonHow can you help prevent shortages of antibiotics this seasonHow can you help prevent shortages of antibiotics this seasonHow can you help prevent shortages of antibiotics this season?

[EU Medicines Agency @EMA_News]

❄️May your holidays be filled with health and well-being. Let's look forward to a new year of advances in science and medicines.

#HappyNewYear #EMAHolidayWish #HealthFirst

[EU Medicines Agency @EMA_News]

EMA and HMA updated their guidance for identifying and disclosing confidential information and personal data in marketing authorisation application of medicines➡️https://t.co/b0Mp07b6w4
This ensures transparency when disclosing information to the public on authorised medicines.

[EU Medicines Agency @EMA_News]

Our Executive Director, Emer Cooke, takes stock of EMA's 2024 achievements.
This is the first year EMA issued more than 100 positive opinions for a marketing authorisation since 2009.
Read the full end-of-year message: https://t.co/BIOlzkEYnP #EU #PublicHealth

[EU One Health @EU_Health]

📣Attention clinical trials sponsors!
New year will come with important changes: 30 Jan 2025 marks the end of the transition period to the new Clinical Trials Regulation (CTR).
Ensure your compliance:
🔗 https://t.co/dr84XXcp8C
#HealthUnion

[EU Medicines Agency @EMA_News]

New report outlines next steps towards use of electronic product information in the #EU!

This will allow patients and prescribers to access vital, up-to-date information on their medicines more quickly and easily 💻

Learn more: https://t.co/E8BG3QxRjC #digitalhealth

[EU Medicines Agency @EMA_News]

First treatment for peripheral thyrotoxicosis in patients with Allan-Herndon-Dudley syndrome 👉 https://t.co/yPuDDhlcOO

[EU Medicines Agency @EMA_News]

📢 EMA recommends 17 new medicines 💊 for approval:
☑️ 1st medicine to treat #vonHippel-Lindau disease
☑️ 1st treatment for for #PeripheralThyrotoxicosis in patients with Allan-Herndon-Dudley syndrome
☑️ 2 medicines to treat #cancer
👉https://t.co/TxVBs8hR9O

[EU Medicines Agency @EMA_News]

First medicine to treat rare genetic disorder causing cysts and tumours 👉 https://t.co/XhgAMDFdSV

[FDA Drugs and Biologics @FDADrugs]

Today, CDER announced the new Center for Real-World Evidence Innovation (CCRI) which aims to coordinate, advance, and promote the use of real-world data (RWD) and real-world evidence (RWE) in regulatory decision-making: https://t.co/WEtw7IBgkV

[EU One Health @EU_Health]

Medical Devices: Have your say on the EU rules!
We’ve launched a public consultation & call for evidence on how EU medical device regulations are performing in practice.
📅 Deadline: 21 March 2025
Participate here:
🔗 https://t.co/LvKZrSd8AV
#HealthUnion

[EU Medicines Agency @EMA_News]

The agenda of EMA's human medicines committee #CHMP is now published.💊💉

Find out what medicines will be discussed this month
https://t.co/ZINgnrXB4n

The committee highlights will be released on Friday.